The Great DTC Debate — Round 1: Are Drug Marketers an Endangered Species?
Robert Ehrlich, CEO and Chairman,DTC Perspectives, Inc., joins John Mack, Editor of Pharma Marketing News and creator of Pharma Marketing Blog, to debate whether or not DTC marketers are being pushed to extinction by government regulations and other forces.
Pharma’s Digital IQ: Measuring the Digital Competence of Pharma Brands
A conversation with Scott Hagedorn (PHD Network CEO) and Scott Galloway (L2 founder and NYU Professor of Brand Strategy) about the L2 Digital IQ Index for pharmaceutical brands, a first-of-its kind measurement of the digital competence of 51 pharma brands across eight therapeutic categories.
Pharma Crisis Communications in the Fast-Paced Digital World: The J&J/McNeil Case Study
A conversation with Bill Silberg (Principal at Silberg Consulting), Melissa Davies (Social Media Practice Lead at Return on Focus) Michael Parks (Executive Vice President, Vox Medica, Inc.), and invited ePharma Pioneer Club members about
PharmaShine: A Laser Look Into Physician Payments
A conversation with George Dunston, Co-Founder and Managing Principal of Obsidian HDS, about PharmaShine, an online service called PharmaShine that makes all of the publicly revealed payments to physicians by pharmaceutical companies available in a searchable interface.
Aligning Your Message with Patient Needs: How Social Media Can Help
A conversation with Tom O'Brien, CMO at MotiveQuest LLC, about using social media data mining to spot patterns in conversations early so that pharma marketers can better align their messages with the needs and concerns of consumers and patients.
Solving the Medical Marketing Blues
A conversation with Reprints Desk's Scott Ahlberg, Head of Corporate Services, and Christian Gray, Business Development, about solving pharma's
Scientist vs Salesman: Which approach will enable your sales reps to raise their value...
A conversation with Tim Ryan, Executive Director of Prescription Medicines, Training, and Development at Boehringer Ingelheim, about his upcoming presentation/panel discussion at eyeforpharma's Sales Force Effectiveness USA 2010 conference on May 17-18 in Princeton, NJ.
Online Community Management: Moderation Best Practices & Other Tips for Pharma Social Media Managers
A conversation with Jenna Woodul, EVP, Chief Community Officer, LiveWorld, Inc., about how pharma companies can manage their social media interactions using technology and
What Sanofi-Aventis Learned from Its FaceBook Experience & What the Experts Recommend It Do...
A conversation with Dennis Urbaniak, VP U.S. Diabetes at sanofi-aventis, about the recent activity on S-A's VOICES corporate Facebook page. We'll discuss the lessons learned and hear advice from independent experts. Urbaniak is willing to answer questions and consider advice from listeners.
Teaching Pharma Social Marketing to Biotech Scientists
A conversation with Eric S. Langer, Adjunct Faculty Member, Johns Hopkins University, and President/Managing Partner of BioPlan Associates, Inc., about teaching
